A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in theCDKN2Tumor-Suppressor Gene
- 12 October 1995
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 333 (15), 975-977
- https://doi.org/10.1056/nejm199510123331505
Abstract
The distinguishing characteristics of familial cancer syndromes are an inherited predisposition to one or more characteristic types of tumors, early age at onset, and multiple synchronous or asynchronous tumors. Recently, the genes responsible for a number of inherited cancers have been identified.1-5Keywords
This publication has 17 references indexed in Scilit:
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994
- Germline p16 mutations in familial melanomaNature Genetics, 1994
- Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locusNature Genetics, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature, 1993
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993
- Identification of FAP Locus Genes from Chromosome 5q21Science, 1991
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990
- SAMPLE PREPARATION FROM PARAFFIN-EMBEDDED TISSUESPublished by Elsevier BV ,1990
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988